The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Vifor Fresenius Medical Care Renal Pharma FranceEU/1/17/1179/004-006

Main Information

Trade NameVeltassa
Active SubstancesPatiromer sorbitex calcium
Dosage FormPowder for oral suspension
Licence HolderVifor Fresenius Medical Care Renal Pharma France
Licence NumberEU/1/17/1179/004-006

Group Information

ATC CodeV03AE Drugs for treatment of hyperkalemia and hyperphosphatemia
V03AE09 Patiromer Calcium


License statusAuthorised
Licence Issued19/07/2017
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back